Allurion Technologies Inc Quick Ratio (ALUR) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Allurion Technologies Inc   (ALUR)

Allurion Technologies Inc 's Quick Ratio

ALUR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2026, Quick Ratio deteriorated to 0.14 below Allurion Technologies Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 192 other companies have achieved higher Quick Ratio than Allurion Technologies Inc in first quarter 2026. While Quick Ratio total ranking in the first quarter 2026 has deteriorated compared to the prior quarter from 3385 to 4099.

Explain Quick Ratio?
How much Cash & cash equivalents ALUR´s has?
What are ALUR´s Current Liabilities?




ALUR Quick Ratio (Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
(Mar 31 2025)
Q1
Y / Y Current Liabilities Change 127.57 % 103.81 % -39.62 % -50.69 % -75.99 %
Y / Y Cash & cash equivalent Change -75.23 % -64.81 % -78.59 % -33.94 % -31.24 %
Quick Ratio MRQ 0.14 0.14 0.53 1.1 1.28
ALUR's Total Ranking # 4099 # 3385 # 1922 # 1427 # 1215
Seq. Current Liabilities Change -5.9 % 230.85 % 0.03 % -26.93 % -15.72 %
Seq. Cash & cash equivalent Change -6.58 % -11.8 % -51.77 % -37.66 % 32.7 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 193
Healthcare Sector # 928
Overall Market # 4099


Quick Ratio Statistics
High Average Low
1.49 0.65 0.05
(Sep 30 2024)   (Jun 30 2023)




Financial Statements
Allurion Technologies Inc 's Current Liabilities $ 36 Millions Visit ALUR's Balance sheet
Allurion Technologies Inc 's Cash & cash equivalent $ 5 Millions Visit ALUR's Balance sheet
Source of ALUR's Sales Visit ALUR's Sales by Geography


Cumulative Allurion Technologies Inc 's Quick Ratio

ALUR's Quick Ratio for the trailling 12 Months

ALUR Quick Ratio

(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth 26.17 % -39.34 % -66.75 % -72.93 % -74.88 %
Y / Y Cash & cash equivalent TTM Growth -64.96 % -51.95 % -52.74 % -53.75 % -45.05 %
Quick Ratio TTM 0.3 0.58 0.94 1.18 1.08
Total Ranking TTM # 4674 # 2977 # 3216 # 3105 # 2835
Seq. Current Liabilities TTM Growth 26.14 % 33.76 % -11.62 % -15.4 % -39.35 %
Seq. Cash & cash equivalent TTM Growth -34.36 % -18.24 % -29.18 % -7.81 % -9.97 %


On the trailing twelve months basis Due to decrease in Current Liabilities in the Q1 2026 to $36.18 millions, cumulative Quick Ratio decreased to 0.3 below the Allurion Technologies Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 217 other companies have achieved higher Quick Ratio than Allurion Technologies Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2025 from 2977 to 4674.

Explain Quick Ratio?
How much Cash & cash equivalents ALUR´s has?
What are ALUR´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 218
Healthcare Sector # 995
Within the Market # 4674


trailing twelve months Quick Ratio Statistics
High Average Low
1.18 0.74 0.3
(Jun 30 2025)   (Mar 31 2026)




Companies with similar Quick Ratio in the quarter ending Mar 31 2026, within Medical Equipment & Supplies Industry Quick RatioMar 31 2026 MRQ Cash & cash equivalentMar 31 2026 MRQ Current Liabilities
Masimo Corp  0.38 $ 124.600  Millions$ 325.400  Millions
U S Physical Therapy Inc  0.38 $ 28.439  Millions$ 74.519  Millions
Iridex Corp  0.36 $ 4.595  Millions$ 12.828  Millions
Heartsciences Inc   0.34 $ 1.657  Millions$ 4.861  Millions
Envue Medical Inc   0.33 $ 2.235  Millions$ 6.865  Millions
Boston Scientific Corporation  0.32 $ 1,453.000  Millions$ 4,571.000  Millions
Cytosorbents Corporation  0.30 $ 4.813  Millions$ 16.303  Millions
Mountain Crest Acquisition Corp V  0.29 $ 0.097  Millions$ 0.329  Millions
Star Equity Holdings Inc   0.29 $ 8.093  Millions$ 27.757  Millions
Solventum Corporation  0.29 $ 561.000  Millions$ 1,961.000  Millions
Retractable Technologies Inc  0.26 $ 2.766  Millions$ 10.446  Millions
Petvivo Holdings Inc   0.26 $ 0.364  Millions$ 1.377  Millions
Ufp Technologies Inc   0.26 $ 19.976  Millions$ 77.013  Millions
Harvard Apparatus Regenerative Technology Inc   0.25 $ 0.419  Millions$ 1.651  Millions
Milestone Scientific Inc   0.25 $ 1.194  Millions$ 4.858  Millions
Bioventus Inc   0.24 $ 35.846  Millions$ 148.095  Millions
Avita Medical Inc   0.24 $ 16.052  Millions$ 66.671  Millions
Nuo Therapeutics Inc   0.20 $ 0.264  Millions$ 1.290  Millions
Accuray Incorporated  0.18 $ 38.067  Millions$ 205.844  Millions
Adm Tronics Unlimited Inc   0.16 $ 0.256  Millions$ 1.560  Millions
National Vision Holdings Inc   0.16 $ 67.898  Millions$ 418.488  Millions
Dentsply Sirona Inc   0.16 $ 190.000  Millions$ 1,207.000  Millions
Nakamoto Inc   0.15 $ 35.300  Millions$ 228.581  Millions
Zimmer Biomet Holdings Inc   0.15 $ 424.200  Millions$ 2,864.300  Millions
Bausch and Lomb Corp  0.15 $ 268.000  Millions$ 1,820.000  Millions
Allurion Technologies Inc   0.14 $ 5.056  Millions$ 36.177  Millions
Infusystem Holdings Inc  0.12 $ 2.106  Millions$ 17.142  Millions
Becton Dickinson And Company  0.12 $ 1,018.000  Millions$ 8,507.000  Millions
Vivos Therapeutics Inc   0.12 $ 2.110  Millions$ 17.937  Millions
Vsee Health Inc   0.11 $ 1.346  Millions$ 11.795  Millions

Date modified: 2026-08-30T15:05:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.